Cargando…
Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity
[Image: see text] Recent studies have shown that nuclear transcription factor cyclic adenosine monophosphate response element binding protein (CREB) is overexpressed in many different types of cancers. Therefore, CREB has been pursued as a novel cancer therapeutic target. Naphthol AS-E and its close...
Autores principales: | Xie, Fuchun, Li, Bingbing X., Kassenbrock, Alina, Xue, Changhui, Wang, Xiaoyan, Qian, David Z., Sears, Rosalie C., Xiao, Xiangshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493896/ https://www.ncbi.nlm.nih.gov/pubmed/26023867 http://dx.doi.org/10.1021/acs.jmedchem.5b00468 |
Ejemplares similares
-
Systemic Inhibition of CREB is Well-tolerated in vivo
por: Li, Bingbing X., et al.
Publicado: (2016) -
Engineered Bacteriophage T7 as a Potent Anticancer Agent in vivo
por: Hwang, Yoon Jung, et al.
Publicado: (2020) -
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
por: He, Jin-Xue, et al.
Publicado: (2016) -
Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma
por: Li, Bingbing X., et al.
Publicado: (2022) -
Small molecule nAS‐E targeting cAMP response element binding protein (CREB) and CREB‐binding protein interaction inhibits breast cancer bone metastasis
por: Jiang, Min, et al.
Publicado: (2018)